These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 5487860
1. [Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations]. Mkrtchian SV, Utkin VV, Egorkina ND. Antibiotiki; 1970 Oct; 15(10):955-7. PubMed ID: 5487860 [No Abstract] [Full Text] [Related]
2. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)]. Bartal M, Nejjar A, Laraki A. Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977 [No Abstract] [Full Text] [Related]
3. [On qualitative demonstration of tuberculostatics in the control of taking of drugs]. Grunert M, Reutgen H, Iwainsky H. Z Tuberk Erkr Thoraxorg; 1965 Jul; 124(3):141-8. PubMed ID: 5899136 [No Abstract] [Full Text] [Related]
4. General survey of the clinical results of treatment of pulmonary tuberculosis with cycloserine in Turkey. Ozgen ZS. Scand J Respir Dis Suppl; 1970 Jul; 71():189-91. PubMed ID: 5271984 [No Abstract] [Full Text] [Related]
6. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis. Bignall JR, Lind A, Rist N. Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884 [No Abstract] [Full Text] [Related]
7. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs]. Zierski M, Zachara A. Gruzlica; 1968 Aug; 37(1):31-8. PubMed ID: 5720035 [No Abstract] [Full Text] [Related]
8. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis]. Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013 [No Abstract] [Full Text] [Related]
11. Ethionamide, pyrazinamide and cycloserine in drug resistant cases. Narang RK, Singh SK. Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462 [No Abstract] [Full Text] [Related]
12. [Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)]. Sighart H, Opl G. Wien Klin Wochenschr; 1969 Nov 04; 81(46):840-1. PubMed ID: 5380791 [No Abstract] [Full Text] [Related]
13. [Attempt at intermittent chemotherapeutic treatment of patients with bacilli resistant to streptomycin and isoniazid (cooperative survey by the antitubercular services of Marrakech, Meknes, Tangiers)]. Burzoni FJ, Chicou FJ, Durante C, Hetrick G, Ras R. Rev Tuberc Pneumol (Paris); 1969 Nov 04; 33(7):975-86. PubMed ID: 5403000 [No Abstract] [Full Text] [Related]
14. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis]. Zierski M, Zacara A, Woźniak S. Gruzlica; 1968 Sep 04; 36(9):809-18. PubMed ID: 4882450 [No Abstract] [Full Text] [Related]
17. [Results of treatment of pulmonary tuberculosis in adults with second line drugs]. Ropek M, Szymański A, Chetkowski A, Tarocińska B. Gruzlica; 1968 Oct 04; 36(10):1043-6. PubMed ID: 5710086 [No Abstract] [Full Text] [Related]
18. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine]. Sighart H, Opl G. Prax Pneumol; 1968 Nov 04; 22(11):692-8. PubMed ID: 5714048 [No Abstract] [Full Text] [Related]
20. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis]. Ivanova ES. Antibiotiki; 1967 Aug 04; 12(8):727-32. PubMed ID: 4968419 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]